These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8410682)

  • 1. Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.
    Ito K; Yamada Y; Nakamura K; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1993 Feb; 21(1):31-41. PubMed ID: 8410682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the therapeutic dose for benzodiazepine anxiolytics based on receptor occupancy theory.
    Ito K; Asakura A; Yamada Y; Nakamura K; Sawada Y; Iga T
    Biopharm Drug Dispos; 1997 May; 18(4):293-303. PubMed ID: 9158878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of pharmacologic effects and toxicity of benzodiazepine hypnotics: role of lipophilicity and plasma elimination rates.
    Arnold J
    J Clin Psychiatry; 1991 Sep; 52 Suppl():11-4. PubMed ID: 1654317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The classification and mechanism of the hypnotics].
    Hashizume Y
    Nihon Rinsho; 1998 Feb; 56(2):510-4. PubMed ID: 9503860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine receptor binding of benzodiazepine hypnotics: receptor and ligand specificity.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1992 Oct; 43(2):413-6. PubMed ID: 1359574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and drug interactions of the sedative hypnotics.
    Wang JS; DeVane CL
    Psychopharmacol Bull; 2003; 37(1):10-29. PubMed ID: 14561946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
    Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.
    Colburn WA; Jack ML
    Clin Pharmacokinet; 1987 Sep; 13(3):179-90. PubMed ID: 2822333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS 7056: a novel ultra-short-acting Benzodiazepine.
    Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
    Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pharmacological profile of clobazam (Mystan), a new antiepileptic drug].
    Nakajima H
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):117-22. PubMed ID: 11530681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine hypnotics: sorting the pharmacokinetic facts.
    Greenblatt DJ
    J Clin Psychiatry; 1991 Sep; 52 Suppl():4-10. PubMed ID: 1680125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.
    Trifiletti RR; Snyder SH
    Mol Pharmacol; 1984 Nov; 26(3):458-69. PubMed ID: 6092896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and clinical studies with a benzodiazepine radioreceptor assay.
    Dorow R
    Psychopharmacology Suppl; 1984; 1():105-18. PubMed ID: 6147835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
    Ishizuka H; Sawada Y; Ito K; Sugiyama Y; Suzuki H; Iga T; Hanano M
    J Pharmacol Exp Ther; 1989 Oct; 251(1):362-7. PubMed ID: 2552078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.
    Hopkins SC; Brian Nofsinger J; Allen MS; Koch P; Varney MA
    Biopharm Drug Dispos; 2009 Jan; 30(1):9-20. PubMed ID: 19152227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are z-hypnotics better and safer sleeping pills than benzodiazepines?].
    Mellingsaeter TC; Bramness JG; Slørdal L
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2954-6. PubMed ID: 17117195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications.
    Quintela O; Sauvage FL; Charvier F; Gaulier JM; Lachâtre G; Marquet P
    Clin Chem; 2006 Jul; 52(7):1346-55. PubMed ID: 16709625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    Sugimoto K; Araki N; Ohmori M; Harada K; Cui Y; Tsuruoka S; Kawaguchi A; Fujimura A
    Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug.
    Kato K; Yasui-Furukori N; Fukasawa T; Aoshima T; Suzuki A; Kanno M; Otani K
    Ther Drug Monit; 2003 Aug; 25(4):473-7. PubMed ID: 12883232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quazepam, a sedative-hypnotic selective for the benzodiazepine type 1 receptor: autoradiographic localization in rat and human brain.
    Wamsley JK; Golden JS; Yamamura HI; Barnett A
    Clin Neuropharmacol; 1985; 8 Suppl 1():S26-40. PubMed ID: 2874881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.